Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone

NCT01544179 ·Status: COMPLETED ·Phase: PHASE3

Iressa 2nd Line Phase III Study in Japan

NCT00252707 ·Status: COMPLETED ·Phase: PHASE3

Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study

NCT00242801 ·Status: COMPLETED ·Phase: PHASE3

An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

NCT00684385 ·Status: APPROVED_FOR_MARKETING

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic

NCT00127829 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

NCT01203917 ·Status: COMPLETED ·Phase: PHASE4

Iressa v BSC (Best Supportive Care) in First Line NSCLC

NCT00259064 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Iressa Case Control Study in Japan

NCT00252759 ·Status: COMPLETED

Phase II Iressa & Carbo/Gem in NSCLC

NCT00264498 ·Status: COMPLETED ·Phase: PHASE2

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00090675 ·Status: WITHDRAWN ·Phase: PHASE3

Iressa as Second Line Therapy in Advanced NSCLC-Asia

NCT00478049 ·Status: COMPLETED ·Phase: PHASE3

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

NCT00173875 ·Status: COMPLETED ·Phase: PHASE2

Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand

NCT01130961 ·Status: COMPLETED

Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC

NCT00188617 ·Status: COMPLETED ·Phase: PHASE2

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

NCT00322452 ·Status: COMPLETED ·Phase: PHASE3

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

NCT00104728 ·Status: TERMINATED ·Phase: NA

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

NCT00059722 ·Status: COMPLETED ·Phase: PHASE2

Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer

NCT00193336 ·Status: COMPLETED ·Phase: PHASE2

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa

NCT01448187 ·Status: COMPLETED

Phase II Iressa Versus Vinorelbine (INVITE)

NCT00256711 ·Status: COMPLETED ·Phase: PHASE2

Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)

NCT00770588 ·Status: COMPLETED ·Phase: PHASE4

A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR

NCT00198159 ·Status: TERMINATED ·Phase: PHASE2

Iressa/Docetaxel in Non-Small-Cell Lung Cancer

NCT00048087 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer

NCT00255489 ·Status: COMPLETED ·Phase: PHASE1

Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients

NCT02025218 ·Status: TERMINATED ·Phase: PHASE2